Clinical trial
Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
NCT04226547 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- July 7, 2020
- Completion date
- April 30, 2031
- Enrollment
- 2,650 (estimated)
- Sites
- 127
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, bleeding, stroke